{"DataElement":{"publicId":"3771225","version":"1","preferredName":"Person HLA Typing Second Allele Antigen Value Collected Outcome","preferredDefinition":"the outcome related to a person in which blood or tissue samples are collected to determine their second series of a given gene per human leukocyte antigen (HLA) profiles.","longName":"PsnHLA2ndXgenVal","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"3771219","version":"1","preferredName":"Person HLA Typing Second Allele Antigen Value Collected","preferredDefinition":"information related to a person in which blood or tissue samples are collected to determine their second series of a given gene per human leukocyte antigen (HLA) profiles.","longName":"PsnHLA2ndXgenClc","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2236731","version":"1","preferredName":"Person","preferredDefinition":"A human being.","longName":"C25190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FC6DF7-66EB-4CAB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-20","endDate":null,"createdBy":"UMLLOADER_MAGE","dateCreated":"2005-06-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3761975","version":"1","preferredName":"HLA Typing Second Allele Antigen Value Collected","preferredDefinition":"A process in which blood or tissue samples are analyzed to determine their human leukocyte antigen (HLA) profiles.:Coming next after the first in position in space or time or degree or magnitude.:one of a series of possible alternative forms of a given gene, differing in DNA sequence, and affecting the functioning of a single product.:Any substance that appears foreign or potentially adverse to the body and elicits immune response.:A numerical quantity measured or assigned or computed.:Collected; brought together in one place.","longName":"3761975v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HLA Typing","conceptCode":"C71329","definition":"A process in which blood or tissue samples are analyzed to determine their human leukocyte antigen (HLA) profiles.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Second","conceptCode":"C25666","definition":"Coming next after the first in position in space or time or degree or magnitude.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Allele","conceptCode":"C16277","definition":"Mutually exclusive alternative forms of the same gene occupying the same locus on homologous chromosomes, differing in nucleotide sequence and governing the same biochemical and developmental process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Antigen","conceptCode":"C268","definition":"Any substance, generally a protein, that stimulates the immune system and elicits an immune response.  Recognition by the immune system elicits either a T-lymphocyte response, recognizing processed antigens, or a B-lymphocyte response, producing antibodies that bind to unprocessed antigens.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Collected","conceptCode":"C25452","definition":"Collected; brought together in one place.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCB1C682-34A5-4B3A-E040-BB89AD430E66","latestVersionIndicator":"Yes","beginDate":"2013-05-14","endDate":null,"createdBy":"WONGW","dateCreated":"2013-05-14","modifiedBy":"ONEDATA","dateModified":"2013-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DD6647E8-A21A-891F-E040-BB89AD434DBE","latestVersionIndicator":"Yes","beginDate":"2013-05-23","endDate":null,"createdBy":"WONGW","dateCreated":"2013-05-23","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":" Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3761967","version":"1","preferredName":"HLA Antigen Value Outcome","preferredDefinition":"an outcome or result of measured blood or tissue samples analyzed to determine human leukocyte antigen (HLA) profiles.","longName":"HLAXgenValOc","context":"COG","contextVersion":"1","type":"Non-enumerated","dataType":"ALPHANUMERIC","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2476191","version":"1","preferredName":"Result","preferredDefinition":"Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"11CE3EF3-93C8-1DC4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-19","modifiedBy":"ONEDATA","dateModified":"2006-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCB1363C-F1F7-282F-E040-BB89AD437D7E","latestVersionIndicator":"Yes","beginDate":"2013-05-14","endDate":null,"createdBy":"WONGW","dateCreated":"2013-05-14","modifiedBy":"SBR","dateModified":"2014-01-02","changeDescription":" Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"HLA 2nd Antigen Value:","type":"Preferred Question Text","description":"HLA 2nd Antigen Value:","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Recipient typing of HLA A (second antigen):","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Donor typing of HLA A (second antigen):","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DD6647E8-A259-891F-E040-BB89AD434DBE","latestVersionIndicator":"Yes","beginDate":"2013-05-23","endDate":null,"createdBy":"WONGW","dateCreated":"2013-05-23","modifiedBy":"KUMMEROA","dateModified":"2022-07-18","changeDescription":". Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}